Inc., an integrated clinical-stage biopharmaceutical company dedicated to developing inhaled medicines, today announced the ...

“Preventing unnecessary exposure to air pollution and consistently wearing masks in high-risk environments can significantly ...

In a cohort of adults with chronic obstructive pulmonary disease (COPD), receiving fluticasone-umeclidinium-vilanterol was ...

Dr. Andy Whittamore, a GP and clinical lead at Asthma and Lung UK, shed light on four chronic lung conditions that tend to ...

Metered-dose inhaler budesonide-glycopyrrolate-formoterol (Breztri Aerosphere) was associated with a higher risk of a first moderate or severe COPD exacerbation (HR 1.09, 95% CI 1.04-1.14 ...

DOI: 10.1136/bmj-2024-080409 Meng-Ting Wang et al, Environmentally friendly inhaler regimens for COPD, BMJ (2024). DOI: 10.1136/bmj.q2825 ...

Wintertime is occasionally difficult for people with chronic respiratory issues. Whether you have asthma, COPD, or a ...

AstraZeneca’s Fasenra, an IL-5-targeting monoclonal antibody already approved for asthma, represents a promising contender ...

Breathing difficulties are also on the rise across Detroit, particularly impacting those with heart conditions and ...

AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

Individuals with early-onset COPD and rapidly progressive pre-COPD frequently have a decades-long history of impaired FEV1/FVC trajectory and wheeze.

MRI of inhaled perfluoropropane can assess regional lung ventilation and monitor improvements in response to medication ...